AI-enhanced breast MRI with a 75% reduced gadolinium dose maintained diagnostic sensitivity comparable to full-dose protocols.
Key Details
- 1Single-center study with 20 female participants having biopsy-proven malignancies or high-risk indications.
- 2Low-dose (0.025 mmol/kg) MRI scans with AI were compared to standard-dose (0.1 mmol/kg) with/without AI.
- 3Diagnostic sensitivity with low-dose + AI was 83.3% (p=1 vs. standard), accuracy was 74.5% vs. 69.5% (standard) and 65.5% (standard+AI).
- 498 lesions detected; 12 were biopsy-proven malignancies; high NPVs (93-94%) across all protocols.
- 5AI-assisted low-dose MRI had the highest PPV (50%) and substantial interreader agreement (kappa 0.65-0.74).
- 6Study was small and lacked long-term outcome data; funded by Bracco.
Why It Matters
Gadolinium retention and cost are growing concerns in breast imaging. This study shows that AI-powered image enhancement could allow safer, lower-dose protocols without compromising cancer detection, marking a significant step for both patient safety and clinical feasibility.
Source
AuntMinnie
Related News
•Radiology Business
Meta Funds Ohio State’s Radiology AI Innovation Projects
Meta will fund Ohio State researchers to explore AI-driven advancements in radiology, including chest X-ray reporting and disease prediction.
•AuntMinnie
AI Triage Tool Speeds Up ICH Head CT Turnaround in ED
AI-based triage for intracranial hemorrhage on head CT reduced emergency department report turnaround by 13 minutes.
•AuntMinnie
ChatGPT-5 Performs Poorly at Detecting Distal Radius Fractures on X-rays
ChatGPT-5 missed about half of distal radius fractures on x-rays, showing limited diagnostic capability in a real-world scenario.